High rate of completion for weekly rifapentine plus isoniazid treatment in Chinese children with latent tuberculosis infection-A single center study.
Three months of weekly rifapentine plus isoniazid (3HP) is a short course regimen for latent tuberculosis infection treatment with satisfied safety and efficacy. However, research on its use in children is limited. In this study, we evaluated the completion rate and safety of the 3HP regimen among c...
Guardado en:
Autores principales: | , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d870e0a6b3914df782c79e3639dbd6f6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:d870e0a6b3914df782c79e3639dbd6f6 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:d870e0a6b3914df782c79e3639dbd6f62021-12-02T20:10:44ZHigh rate of completion for weekly rifapentine plus isoniazid treatment in Chinese children with latent tuberculosis infection-A single center study.1932-620310.1371/journal.pone.0253159https://doaj.org/article/d870e0a6b3914df782c79e3639dbd6f62021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0253159https://doaj.org/toc/1932-6203Three months of weekly rifapentine plus isoniazid (3HP) is a short course regimen for latent tuberculosis infection treatment with satisfied safety and efficacy. However, research on its use in children is limited. In this study, we evaluated the completion rate and safety of the 3HP regimen among children in China. Participants aged 1-14 years receiving 3HP for TB prevention at Shanghai Public Health Clinical Center were followed from December 2019 to November 2020 to evaluate the safety and completion rate of the treatment. Thirty-one children were eligible for inclusion, but five were excluded from the analysis (three were treated with a lower than recommended dose, and two were lost to follow-up). Of the 26 children included in the analysis, the treatment completion rate was 100%. Adverse drug reactions (ADRs) were reported in 38.5% (10/26) of the patients. The most common ADRs were gastrointestinal symptoms (19.2%,5/26), and all ADRs were rated as Grade 1. The 3HP regimen has a high completion rate, and it seems well tolerated in our study population. However, further randomized controlled clinical trial with larger sample size are warranted.Heng YangYang YangZhi-Dong HuLu XiaXu-Hui LiuXin YuJia-Ye MaTao LiShui-Hua LuPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 6, p e0253159 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Heng Yang Yang Yang Zhi-Dong Hu Lu Xia Xu-Hui Liu Xin Yu Jia-Ye Ma Tao Li Shui-Hua Lu High rate of completion for weekly rifapentine plus isoniazid treatment in Chinese children with latent tuberculosis infection-A single center study. |
description |
Three months of weekly rifapentine plus isoniazid (3HP) is a short course regimen for latent tuberculosis infection treatment with satisfied safety and efficacy. However, research on its use in children is limited. In this study, we evaluated the completion rate and safety of the 3HP regimen among children in China. Participants aged 1-14 years receiving 3HP for TB prevention at Shanghai Public Health Clinical Center were followed from December 2019 to November 2020 to evaluate the safety and completion rate of the treatment. Thirty-one children were eligible for inclusion, but five were excluded from the analysis (three were treated with a lower than recommended dose, and two were lost to follow-up). Of the 26 children included in the analysis, the treatment completion rate was 100%. Adverse drug reactions (ADRs) were reported in 38.5% (10/26) of the patients. The most common ADRs were gastrointestinal symptoms (19.2%,5/26), and all ADRs were rated as Grade 1. The 3HP regimen has a high completion rate, and it seems well tolerated in our study population. However, further randomized controlled clinical trial with larger sample size are warranted. |
format |
article |
author |
Heng Yang Yang Yang Zhi-Dong Hu Lu Xia Xu-Hui Liu Xin Yu Jia-Ye Ma Tao Li Shui-Hua Lu |
author_facet |
Heng Yang Yang Yang Zhi-Dong Hu Lu Xia Xu-Hui Liu Xin Yu Jia-Ye Ma Tao Li Shui-Hua Lu |
author_sort |
Heng Yang |
title |
High rate of completion for weekly rifapentine plus isoniazid treatment in Chinese children with latent tuberculosis infection-A single center study. |
title_short |
High rate of completion for weekly rifapentine plus isoniazid treatment in Chinese children with latent tuberculosis infection-A single center study. |
title_full |
High rate of completion for weekly rifapentine plus isoniazid treatment in Chinese children with latent tuberculosis infection-A single center study. |
title_fullStr |
High rate of completion for weekly rifapentine plus isoniazid treatment in Chinese children with latent tuberculosis infection-A single center study. |
title_full_unstemmed |
High rate of completion for weekly rifapentine plus isoniazid treatment in Chinese children with latent tuberculosis infection-A single center study. |
title_sort |
high rate of completion for weekly rifapentine plus isoniazid treatment in chinese children with latent tuberculosis infection-a single center study. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2021 |
url |
https://doaj.org/article/d870e0a6b3914df782c79e3639dbd6f6 |
work_keys_str_mv |
AT hengyang highrateofcompletionforweeklyrifapentineplusisoniazidtreatmentinchinesechildrenwithlatenttuberculosisinfectionasinglecenterstudy AT yangyang highrateofcompletionforweeklyrifapentineplusisoniazidtreatmentinchinesechildrenwithlatenttuberculosisinfectionasinglecenterstudy AT zhidonghu highrateofcompletionforweeklyrifapentineplusisoniazidtreatmentinchinesechildrenwithlatenttuberculosisinfectionasinglecenterstudy AT luxia highrateofcompletionforweeklyrifapentineplusisoniazidtreatmentinchinesechildrenwithlatenttuberculosisinfectionasinglecenterstudy AT xuhuiliu highrateofcompletionforweeklyrifapentineplusisoniazidtreatmentinchinesechildrenwithlatenttuberculosisinfectionasinglecenterstudy AT xinyu highrateofcompletionforweeklyrifapentineplusisoniazidtreatmentinchinesechildrenwithlatenttuberculosisinfectionasinglecenterstudy AT jiayema highrateofcompletionforweeklyrifapentineplusisoniazidtreatmentinchinesechildrenwithlatenttuberculosisinfectionasinglecenterstudy AT taoli highrateofcompletionforweeklyrifapentineplusisoniazidtreatmentinchinesechildrenwithlatenttuberculosisinfectionasinglecenterstudy AT shuihualu highrateofcompletionforweeklyrifapentineplusisoniazidtreatmentinchinesechildrenwithlatenttuberculosisinfectionasinglecenterstudy |
_version_ |
1718374975646203904 |